Small Change – Big Consequences: Low Level Antibiotic Exposure Drives Rapid Evolution of Multidrug Resistance in Microbial Biofilms
07 November 2019
It was only in the last few decades that biofilms are recognized for what they are – the natural lifestyle for majority of bacteria. As a result, there are many things we still don’t know about biofilms.
Further reading: Nature Microbiology
Author(s): Anahit Penesyan
Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
